Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM)
Market Open
11 Aug, 10:00
XNSE XNSE Primary MSE ₹
230. 61
-2.36
-1.013%
₹
12.36B Market Cap
34.78 P/E Ratio
10% Div Yield
9,252 Volume
0 Eps
₹ 232.97
Previous Close Want to track JAGSNPHARM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Statistics
Valuation metrics
Market Cap 12.36B
Enterprise value 15.22B
Trailing P/E (ttm) 34
Forward P/E -
PEG ratio -1.37
Price/Sales (ttm) 5.18
Price/Book (mrq) 5.51
Enterprise Value/Revenue 5.18
Enterprise Value/EBITDA 22.32
Overview
Shares outstanding 66.96M
Float 16.03M
Shares short -
% Held by insiders 0.76%
% Held by institutions 0.03%
Average volume (10 days) 1.91M
Average volume (90 days) 502.82K
Price summary
52-Week low 155
52-Week high 264.5
Beta -0.48
50-Day moving average 229.4
200-Day moving average 199.98
Dividends and splits
Forward annual dividend rate 10
Forward annual dividend yield 0.0541%
Trailing annual dividend rate 2.5
Trailing annual dividend yield 0.0108%
5-Year annual dividend yield 0.87%
Payout ratio 0.37
Dividend Date 24 Oct 2025
Ex-Dividend Date 12 Sep 2025
Last split factor 2:1
Last split Date 8 Jan 2025
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.15%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.17%
Income Statement
Revenue (ttm) 2.82B
Revenue per share (ttm) 44.63
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 1.79B
EBITDA 671.26M
Net income to common (ttm) 409.03M
Diluted EPS (ttm) 6.91
Quarterly earnings growth (yoy) -0.66%
Balance Sheet
Total cash (mrq) 1.59B
Total cash per share (mrq) 16.13
Total debt (mrq) 88.36M
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 5.06%
Book value per share (mrq) 41.95
Cash Flow
Cash flow statement 532.93M
Levered free cash flow (LFCF) 553.61M
